Managing supply chain disruption in the life sciences and health care industry: Part 2 – Supply chain resilience and supply chain litigation/arbitration

We held the second webinar in the managing supply chain disruption in the Life Sciences sector webinar series on 25 June.

The COVID-19 pandemic has been a stress test for businesses' supply chain(s). We took a look at supply chain arbitration/litigation as a consequence of a COVID-19 related supply chain disruptions. We also took a forward looking approach: What are the lessons learned, and what can be done to improve supply chain resilience in the future? Our global team discussed supply chain litigation/arbitration and supply chain resilience.

Part 2 – Supply chain resilience and supply chain litigation/arbitration

  • The COVID-19 supply chain disruption: What you need to know about supply chain litigation/arbitration.
  • Lessons learned: What can I do to improve supply chain resilience?


Back To Listing
Loading data